Testing effectiveness (Phase 2)Study completedNCT03702179
What this trial is testing
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach
Who this might be right for
Invasive Bladder Cancer
Spanish Oncology Genito-Urinary Group 32